References
#1 1. Iannuzzi MC, Rybicki BA, Teirstein AS. Sarcoidosis. N Engl J Med . 2007;357(21):2153-2165. doi:10.1056/NEJMra071714
2. Lower EE, Broderick JP, Brott TG, Baughman RP. Diagnosis and management of neurological sarcoidosis. Arch Intern Med . 1997;157(16):1864-1868.
3. Stern BJ, Krumholz A, Johns C, Scott P, Nissim J. Sarcoidosis and its neurological manifestations. Arch Neurol . 1985;42(9):909-917. doi:10.1001/archneur.1985.04060080095022
4. Smith JK, Matheus MG, Castillo M. Imaging manifestations of neurosarcoidosis. AJR Am J Roentgenol . 2004;182(2):289-295. doi:10.2214/ajr.182.2.1820289
5. Hoitsma E, Faber CG, Drent M, Sharma OP. Neurosarcoidosis: a clinical dilemma. Lancet Neurol . 2004;3(7):397-407. doi:10.1016/S1474-4422(04)00805-1
6. Burns TM. Neurosarcoidosis. Arch Neurol . 2003;60(8):1166-1168. doi:10.1001/archneur.60.8.1166
7. COLOVER J. SARCOIDOSIS WITH INVOLVEMENT OF THE NERVOUS SYSTEM.Brain . 1948;71(4):451-475. doi:10.1093/brain/71.4.451
8. Ginat DT, Dhillon G, Almast J. Magnetic resonance imaging of neurosarcoidosis. J Clin Imaging Sci . 2011;1:15. doi:10.4103/2156-7514.76693
9. Stern BJ, Royal W 3rd, Gelfand JM, et al. Definition and Consensus Diagnostic Criteria for Neurosarcoidosis: From the Neurosarcoidosis Consortium Consensus Group. JAMA Neurol . 2018;75(12):1546-1553. doi:10.1001/jamaneurol.2018.2295
10. Zajicek JP, Scolding NJ, Foster O, et al. Central nervous system sarcoidosis–diagnosis and management. QJM . 1999;92(2):103-117. doi:10.1093/qjmed/92.2.103
11. Lacomis D. Neurosarcoidosis. Curr Neuropharmacol . 2011;9(3):429-436. doi:10.2174/157015911796557975
12. Yacoub HA, Al-Qudah ZA SN. Cranial neuropathies in sarcoidosis.World J Ophthalmol . 2015;5(1):16-22.
13. Krumholz A, Stern BJ, Stern EG. Clinical implications of seizures in neurosarcoidosis. Arch Neurol . 1991;48(8):842-844. doi:10.1001/archneur.1991.00530200084023
14. S.E. Knapen, P. Goswani KMAV. Uw Diagnose? Tijdschr Neurol Neurochir . 2019;120(4):161-163.
15. Bathla G, Singh AK, Policeni B, Agarwal A, Case B. Imaging of neurosarcoidosis: common, uncommon, and rare. Clin Radiol . 2016;71(1):96-106. doi:10.1016/j.crad.2015.09.007
16. Jachiet V, Lhote R, Rufat P, et al. Clinical, imaging, and histological presentations and outcomes of stroke related to sarcoidosis. J Neurol . 2018;265(10):2333-2341. doi:10.1007/s00415-018-9001-x
17. Brown MM, Thompson AJ, Wedzicha JA, Swash M. Sarcoidosis presenting with stroke. Stroke . 1989;20(3):400-405. doi:10.1161/01.str.20.3.400
18. Hesselmann V, Wedekind C, Terstegge K, et al. An isolated fourth ventricle in neurosarcoidosis: MRI findings. Eur Radiol . 2002;12 Suppl 3:S1-3. doi:10.1007/s00330-002-1369-3
19. Voortman M, Daan Fritz, O.J.M. Vogels, D. van de Beek, J. de Vries, Mieke C. Brouwer MD. Clinical manifestations of neurosarcoidosis in the Netherlands. J Neurol Neurosci . 2019;10(2):292.